Results 191 to 200 of about 35,587 (246)

IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom [PDF]

, 2012
Florian Stockhammer, Martin Misch, Hans-Joachim Helms, Ulrike Lengler, Friedrich Prall, Andreas von Deimling, Christian Hartmann   +6 more
openalex   +1 more source

Role of Multiparametric Ultrasound in Predicting the IDH Mutation in Gliomas: Insights from Intraoperative B-Mode, SWE, and SMI Modalities. [PDF]

J Clin Med
Cai S, Xing H, Wang Y, Wang Y, Ma W, Jiang Y, Li J, Wang H.   +7 more
europepmc   +1 more source

FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery. [PDF]

Clin Cancer Res
Barbato MI, Barone AK, Aungst SL, Miller CP, Ananthula S, Bi Y, Yang Y, Li X, Xiong Y, Fan J, Dorff SE, Zhao H, Zhou H, Pradhan S, Scepura B, Sinha AK, Stephenson M, Bhatnagar V, Saber H, Rahman NA, Tang S, Pazdur R, Kluetz PG, Larkins E, Drezner N.   +24 more
europepmc   +1 more source

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations. [PDF]

Oncologist
Nguyen MK, Jelinek M, Singh A, Isett B, Myers ES, Mullett SJ, Eisele Y, Beumer JH, Parise RA, Urban J, Rose A, Sellitto L, Singh K, Doerfler R, Dadey RE, Kim C, Rhee JC, Davar D, Villaruz LC, Burgess M, Drappatz J, Mantica M, Goodman AE, Wang H, Singhi AD, Luke JJ, Zandberg DP, Bao R.   +27 more
europepmc   +1 more source

Unveiling prognosis in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax through novel risk stratification. [PDF]

Leuk Res Rep
Sun J, Guo Z.
europepmc   +1 more source

RNaseH2 inhibition potentiates temozolomide response in patient derived glioblastoma cells. [PDF]

Sci Rep
Kissova M, Martinez Segarra J, Iveland TS, Vestvik M, Ravlo E, Wang W, Hagen L, Liabakk NB, Camara-Quilez M, Arano Barenys M, Solheim O, Hoff BH, Sundby E, Bjørås M, Slupphaug G, Visnes T, Brambilla A.   +16 more
europepmc   +1 more source

Supplementary Figure S4 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma [PDF]

Fengqi Zhou, Yuanyuan Sun, Xinhua Chen, Di Wu, Zhennan Tao, Lingyun Wu, Gao Chen, Xiangyu Liu, Tianfu Yu   +8 more
openalex   +1 more source

Profiling ADC targets in cholangiocarcinoma: implications for therapeutic development. [PDF]

NPJ Precis Oncol
Nakazawa M, Arif W, Baraban E, Matoso A, Hallab E, Kartalia E, Azad NS, Baretti M, Zabransky DJ, Anders RA, Oshima K, Yarchoan M.   +11 more
europepmc   +1 more source

Supplementary Table S2 from Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance [PDF]

Stephen V Carney, Kaushik Banerjee, Anzar Mujeeb, Brandon Zhu, Santiago Haase, María L. Varela, Padma Kadiyala, Claire E. Tronrud, Ziwen Zhu, Devarshi Mukherji, Preethi Gorla, Yi-Lun Sun, Rebecca Tagett, Felipe J. Nunez, Maowu Luo, Weibo Luo, Mats Ljungman, Yayuan Liu, Ziyun Xia, Anna Schwendeman, Tingting Qin, Maureen A. Sartor, Joseph F. Costello, Daniel P. Cahill, Pedro R Lowenstein, Maria G. Castro   +25 more
openalex   +1 more source

Joint prediction of glioma molecular marker status based on GDI-PMNet. [PDF]

J Transl Med
Zhu H, Liang F, Zhao T, Cao Y, Chen Y, Yan H, Xiao X.   +6 more
europepmc   +1 more source